5-Azacitidine in Low-risk Myelodysplastic Syndromes (MDSs)

Clinical trial NCT00897130 · COMPLETED

Trial details

NCT number: NCT00897130
Sponsor: Università degli Studi di Brescia
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Myelodysplastic Syndrome

Start date: 2008-08-01
Primary completion: 2009-12-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.